The Global Anxiety Disorder Treatment Market Share to Witness Major Growth

Wiseguy0109 Mar, 2023News

Numerous established players dominate the Anxiety Disorder Treatment Market share. The key players are involved in strategic initiatives to strengthen their market positions and expand their geographic presence in developing regions. Many players are investing in research activities to develop effective therapies to sustain in the market. For instance, Eli Lilly and Company launched Duloxetine and Forest Laboratories, Inc. launched Vilazodone, used for the treatment of generalized anxiety disorder.